Streetbeat News

Stock Prices

IRT

JMP Securities analyst Aaron Hecht maintains a Market Outperform rating on Independence Realty Trust (NYSE:IRT) and raises the price target from $15 to $17.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 6:16 pm

APO

BLK

LTRPA

TRIP

Apollo Global Management Inc (NYSE:APO) is reportedly interested in acquiring TripAdvisor Inc (NASDAQ:TRIP), part of John Malone's Liberty Media group. The discussions are in early stages, with TripAdvisor engaging advisers to explore potential acquisition proposals. TripAdvisor's shares have risen 25% over the last year, despite a recent slight decline. Liberty TripAdvisor Holdings Inc (OTC:LTRPA) is the primary shareholder, with significant influence. Other notable stakeholders include BlackRock Inc (NYSE:BLK) and Vanguard Group Inc. TripAdvisor's Q4 revenue was $390.00 million, a 10% increase year-on-year.

Portfolio Pulse from Anusuya Lahiri

March 06, 2024 | 6:15 pm

EVC

EF Hutton analyst Edward Reilly downgraded Entravision Comms (EVC) from Buy to Hold and set a price target of $1.75.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 6:12 pm

SWIN

Solowin Holdings' shares resumed trading and were then halted again due to a circuit breaker triggered by a significant upward movement, with the stock now up 128.4%.

Portfolio Pulse from Benzinga Newsdesk

March 06, 2024 | 6:05 pm

XRX

Xerox Holdings Corporation (NASDAQ:XRX) shares fell after announcing a $300 million convertible senior notes offering and an increase in the maximum tender cap for certain senior notes. The proceeds are intended for capped call transactions and general corporate purposes. This follows a reported Q4 sales decline of 9.1% Y/Y, with equipment sales and post-sale revenue also down. XRX shares are currently down 9.21% at $17.06.

Portfolio Pulse from Lekha Gupta

March 06, 2024 | 6:03 pm

NEPH

Nephros (NASDAQ:NEPH) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $-0.02. Analysts and investors are keen on not just the earnings beat or miss but also the company's guidance for future growth. Historically, Nephros has had mixed results in beating EPS estimates, with share price reactions varying post-earnings announcement. The stock has seen a significant increase of 201.13% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 6:02 pm

MYO

Myomo (AMEX:MYO) is scheduled to release its quarterly earnings report on March 7, 2024, with analysts expecting an EPS of $-0.06. The company's past performance shows a mixed impact on its stock price post-earnings announcement, with the last quarter showing a 7.39% increase after beating EPS estimates. Shares of Myomo have seen a significant increase of 390.85% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 6:02 pm

LCTX

Lineage Cell Therapeutics (AMEX:LCTX) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $-0.04. The company's past earnings performance shows a consistent EPS estimate of $-0.04 over the last four quarters, with actual EPS slightly beating estimates in Q2 and Q1 2023 but matching the estimate in Q3 2023 and Q4 2022. The stock price reacted with minor fluctuations following these earnings releases. Currently, LCTX shares are trading at $1.08, reflecting a 22.6% decline over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 6:02 pm

WLDN

Willdan Group (NASDAQ:WLDN) is expected to report an EPS of $0.35 in its upcoming quarterly earnings on March 7, 2024. Analysts and investors are looking for an earnings beat and positive guidance for future growth. The company's past earnings performance shows a pattern of beating EPS estimates, leading to significant stock price movements. Shares are currently trading at $20.28, with a 16.52% increase over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 6:02 pm

SQNS

Sequans Communications (NYSE:SQNS) is scheduled to release its quarterly earnings report on March 7, 2024, with an expected EPS of $-0.15. Historical performance shows mixed results with the last quarter missing estimates, leading to a 0.0% change in share price. Over the past year, SQNS shares have declined by 69.45%, indicating a bearish sentiment among long-term shareholders. Investors will be keenly watching for not just the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 06, 2024 | 6:02 pm